Pre-Annual General Meeting Information • Mar 25, 2020
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
If you are in any doubt as to any aspect of the proposals referred to in this document, or as to the action you should take, you should seek your own advice from a stockbroker, solicitor, accountant or other independent financial adviser who, if you are taking advice in the United Kingdom, is duly authorised under the Financial Services and Markets Act 2000 or an appropriately authorised independent financial adviser if you are in a territory outside the United Kingdom.
If you have sold or otherwise transferred all of your shares in the Company, please pass this document together with the accompanying document(s) to the purchaser or transferee, or to the person who arranged the sale or transfer so they can pass these documents to the person who now holds the shares.
(registered in England & Wales no 3299608) Caroline House 55-57 High Holborn London WC1V 6DX
19 March 2020
Dear Shareholder
In the lead up to the AGM, we are closely monitoring the impact of the COVID-19 virus in the United Kingdom and UK Government guidance, in particular on events and gathering. It may become necessary or appropriate to make alternative arrangements to the structure and organisation of the meeting. In those circumstances, we will ensure that shareholders are given as much notice as possible, however the Board encourages shareholders to submit their proxies as early as possible and to be mindful of UK Government guidance. Further information will be made available at: www.elementis.com
As announced on 19 March 2020, due to the ongoing uncertainties arising out of the COVID-19 pandemic, the Board has decided that it is prudent to preserve cash. Therefore, the previously announced proposed 2019 final dividend will no longer be proposed at the AGM.
I am writing to give you notice of the Company's AGM that is to be held at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG on Wednesday 29 April 2020 at 9.00 am.
As you will see from the notice of AGM overleaf, there are a number of items of business to be considered and you will find explanatory notes for each resolution on pages 4 to 9.
The directors believe that in the interests of shareholder democracy, it is important that the voting intentions of all members are taken into account, not just those who are able to attend the AGM and as such we propose putting Resolutions 1 to 18 to shareholders by way of poll rather than a show of hands. Shareholders attending the AGM will still have the opportunity to ask questions and vote on each resolution.
If you would like to vote on the resolutions but cannot come to the AGM, you can appoint a proxy to exercise all or any of your rights to attend, vote and speak at the AGM. You will find a Form of Proxy and an Attendance Card enclosed with this notice. Alternatively, submit an electronic proxy appointment instruction as soon as possible and, in any event, so as to be received by the Company's Registrar at the relevant address set out below by no later than 9.00 am on 27 April 2020. Completion and return of the Form of Proxy or submission of an electronic instruction will not preclude you from attending and voting in person at the AGM should you subsequently decide to do so.
If you have any questions about the AGM or your shareholding, please contact our Registrar, Equiniti, by post at Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA; by telephone on 0371 384 2379 (overseas +44 121 415 7043; or for shareholders who have already registered with Equiniti's online portfolio service; Shareview, on the internet at www.shareview.co.uk (lines are open from 8.30 am to 5.30 pm, Monday to Friday excluding public holidays in England and Wales). Further shareholder information can be found on the Company's corporate website at www.elementis.com
The Board confirms that, in its opinion, all of the resolutions are in the best interests of the Company and its shareholders as a whole and unanimously recommends that shareholders vote in favour of them. The directors intend to vote in favour of the resolutions in respect of their own beneficial shareholdings.
Yours sincerely
ANDREW DUFF Chairman
Notice is hereby given that the 2020 Annual General Meeting ('AGM' or the 'Meeting') of the Company will be held at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG on Wednesday 29 April 2020 at 9.00am to transact the business set out below.
Resolutions 1 to 14 will be proposed as ordinary resolutions and resolutions 15 to 18 will be proposed as special resolutions.
such authorities to apply in substitution for all previous authorities pursuant to Section 551 of the Companies Act and to expire at the end of the next AGM of the Company or on 29 July 2021, whichever is the earlier but, in each case, save that the Company may make offers and enter into agreements during the relevant period which would, or might, require shares to be allotted or rights to subscribe for or to convert any security into shares to be granted after the authority ends.
For the purposes of this Resolution:
(as such terms are defined in Sections 363 to 365 of the Companies Act 2006) provided that the aggregate amount of any such donations and expenditure shall not exceed £50,000 during the period beginning with the date of passing this resolution and expiring at the conclusion of the next AGM of the Company or until the close of business on 29 July 2021, whichever is earlier provided that the authorised sums referred to in paragraphs a), b) and c) above, may be comprised of one or more amounts in different currencies which, for the purposes of calculating the said sums, shall be converted into pounds sterling at the exchange rate published in the London edition of the Financial Times on the date on which the relevant donation is made or expenditure incurred (or the first business day thereafter) or, if earlier, on the day on which the Company enters into any contract or undertaking in relation to the same.
such authority to expire at the end of the next AGM of the Company or on 29 July 2021, whichever is the earlier, save that prior to its expiry, the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.
For the purposes of this Resolution:
such authority to expire at the end of the next AGM of the Company or on 29 July 2021, whichever is the earlier, save that prior to its expiry, the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.
By Order of the Board
Group Company Secretary Registered office: Caroline House 55-57 High Holborn London WC1V 6DX
19 March 2020
The Companies Act 2006 requires the directors of a public company to lay before the company in general meeting copies of the annual report and accounts in respect of each financial year. As such, the Company proposes a resolution on its audited accounts and directors' and auditors' reports for the year ended 31 December 2019. Shareholders will have the opportunity to put any questions to the directors before the resolution is proposed to the Meeting.
The vote will be proposed as an advisory vote to approve the directors' remuneration report for 2019 (excluding the remuneration policy). An advisory vote means the outcome will not affect the actual remuneration paid to any individual director. The directors' remuneration policy was last approved by shareholders at the AGM in 2018 and is only subject to a vote every three years unless changes to policy are being proposed which is not the case this year. The directors' remuneration policy will be put to shareholders again no later than the Company's AGM in 2021.
In accordance with the provisions of the UK Corporate Governance Code concerning the annual re-election of all directors of premium listed companies, all the directors, will be retiring at the AGM and offer themselves for election or re-election by shareholders.
The Board and the Nomination Committee have discussed the Board's succession plans and all non-executive directors, including the Chairman, have indicated their willingness to be re-appointed.
Biographical details of each of the directors standing for either election or re-election are set out below, together with the reasons why their contributions are, and continue to be, important to the Company's long-term sustainable success.
Andrew joined the Board as a Non-Executive Director and Deputy Chairman on 1 April 2014 and was appointed Non-Executive Chairman and Chairman of the Nomination Committee on 24 April 2014.
Andrew has significant boardroom experience gained from serving as a director and chairman of a number of UK and international companies. This combined with experience in the manufacturing, energy and utilities sector, enables Andrew to effectively lead the Board and deliver value to shareholders and other stakeholders.
From 2003 until 2009, Andrew was chief executive officer of npower, the successor entity to Innogy plc which in 2000 was demerged from National Power, restructured and then sold to RWE, the German electricity and gas company. He was also a member of the RWE's executive committee. Before this, he spent 16 years at BP in downstream international markets. Andrew was a nonexecutive director of Wolseley plc, the international plumbing and building materials company, between 2004 and 2013, where he was also the senior independent director and chairman of the remuneration committee.
Andrew holds a BSc (Honours) degree in Mechanical Engineering and is a fellow of the Energy Institute.
British
Paul was appointed Group CEO on 8 February 2016.
Paul has a proven track record in developing markets, products and opportunities for creating value, business optimisation and transformation. Paul's global experience provides the skill set required to deliver the Company's strategy and provide inspiring leadership.
Prior to joining Elementis, Paul was global CEO of the BP lubricants business in 2013 after having overseen the BP Australia/New Zealand downstream business. In 2010, Paul was country president of BP Australia. Prior to this he was CEO of BP's global aviation, industrial, marine and energy lubricants businesses (2009 to 2010) and CEO of BP Lubricants Americas (2007 to 2009). He joined BP after it acquired Burmah-Castrol in 2000, having joined the latter in 1994 after roles at Reckitt Benckiser and Kraft Foods.
Paul holds a BSc degree in Packaging Engineering from Michigan State University and an MBA in Finance and International Business from New York University, Stern School of Business.
American
Ralph was appointed CFO-Designate and an executive director on 12 September 2016, and became Group CFO on 1 November 2016.
Ralph is an accomplished CFO who has a strong track record in finance, strategy development and implementation, and M&A which enables him to provide effective financial leadership to underpin the delivery of the Company's strategy.
Ralph had a 30 year career with BP, where he held a number of significant leadership positions, including roles in financial management, sales and marketing, corporate development (M&A), strategy and planning. In 2010, Ralph was CFO of BP Lubricants and served on the board of Castrol India Limited from 2010 until 2016.
Ralph holds an MA degree in Modern History and Economics from the University of Oxford and an MBA from INSEAD.
British
Sandra was appointed a non-executive director on 1 February 2017.
Sandra brings strategic advisory and corporate finance experience gained as a consultant to complex global companies on transformational change. Her contribution in relation to financial markets alongside risk management in regulated industries provides the Board with valuable insight.
Sandra was a senior partner at McKinsey & Company from 2005 to 2014 (and a partner from 2000), where she specialised in investment banking and risk, and held several senior management positions in the United Kingdom and the United States. At McKinsey, Sandra acted as an adviser to global financial institutions, corporates and public sector bodies on a wide range of strategic, operational and policy issues. Sandra has held other non-executive and advisory appointments with the Institute of International Finance, the McKinsey Master Retirement Trust and the Edith Wharton Restoration.
Sandra has a BA degree in American Studies and Economics from Stanford University and an MBA degree from Harvard Business School.
A, N, R
British/American
Dorothee was appointed a non-executive director on 1 March 2017.
Dorothee provides the Board with valuable insight into the wider European chemicals and life science sector as well as sector specific acquisition expertise.
Dorothee manages her own corporate advisory consultancy serving a number of European clients in the pharma/ biotech sector. She is active in various industry bodies. Her previous executive roles included managing director and head of Corporate Advisory Group (Europe) at UBS in Zurich, head of M&A chemicals and healthcare at a private investment bank in Germany and as a senior executive in the corporate finance department at the Roche group. Dorothee was a former nonexecutive director of Röchling SE & Co (until May 2019).
Dorothee holds a masters degree in Chemistry from the Université Louis Pasteur, Strasbourg and an MBA from INSEAD.
A, N, R
Austrian
Steve was appointed a non-executive director on 20 October 2014 and became chairman of the remuneration committee on 25 April 2017.
Steve has strong and relevant international experience in specialty chemicals businesses, manufacturing and diverse industrial markets which enables him to provide guidance and challenge to management. Steve's involvement with remuneration committees in other organisations enable him to provide judgement and knowledge of topical remuneration matters in his capacity as Remuneration Committee chair.
Steve was chief executive of Low & Bonar plc between September 2009 and September 2014. Prior to that role, he was managing director of its technical textiles division between 2006 and 2009, director of new business between 2005 and 2006, and managing director of its plastics division between 2004 and 2005. Prior to joining Low & Bonar he spent 10 years with BTP plc (now part of Clariant) in a variety of leadership positions managing international speciality chemicals businesses. Steve served as non-executive director and chairman of the remuneration committee of Cape plc from July 2015 to September 2017 and non-executive director of Anglian Water Services and member of the audit committee, nomination committee and remuneration committee from April 2015 to October 2018.
Steve holds a degree in Economics and Financial Management from Sheffield University. He is a chartered accountant.
R*, N
British
Anne was appointed a non-executive director in June 2013 and became chairman of the audit committee on 1 August 2013.
Anne brings substantial financial, internal controls, audit and tax expertise to the Board which enables her to be effective in her role as Audit Committee chair. Anne's background with global organisations enables her to effectively contribute in the context of Elementis' existing markets and new business opportunities.
She is currently CFO of Kymab Group Ltd, a biopharmaceutical company funded by the Wellcome Trust and the Bill & Melinda Gates Foundation. Prior to her current executive role, she was CFO and company secretary of BBI Diagnostics Group Ltd and FTSE-listed Vectura Group plc. Previous senior finance positions held include director of corporate finance at Celltech Group plc, Medeva plc and KPMG.
Anne holds a degree in Business Studies from Trinity College, Dublin and is a chartered accountant (FCA) and a corporate tax adviser (CTA – AITI).
A*, N
Irish
John was appointed a Non-Executive Director on 4 February 2020 and will become Senior Independent Director following the conclusion of the 2020 AGM.
John has strong strategic and operational experience including leading a high technology equipment manufacturer through a period of significant transformation and development. John's background in global markets, chemicals, and manufacturing will enable him to provide valuable knowledge and guidance to the Board.
John served as chief executive of Spectris plc from January 2006 to September 2018, leading the business through a period of significant strategic transformation and development. Prior to Spectris plc, John spent 14 years at Honeywell International in a number of senior management roles including Chairman of Honeywell Automation India and President of Automation & Control for Asia- Pacific. His early career was spent at Daimler Benz A.G. as a research and development engineer.
Previous non-executive director roles include Exide Technologies, a US based supplier of battery technology to automotive and industrial users (from 2010 to 2015).
John holds a master's degree in Mechanical Engineering from Purdue University (USA) and an MBA from INSEAD.
A, N, R
Irish
Resolution 11 relates to the re-appointment of Deloitte LLP as the Company's auditor to hold office until the next AGM of the Company. This resolution is recommended by the Audit Committee and endorsed by the Board. The directors propose the re-appointment of Deloitte LLP. The rationale for this recommendation can be found in the 2019 annual report and accounts on page 76.
Resolution 12 authorises the Audit Committee of the Board to set the auditor's remuneration. The Audit Committee considers that the nature and level of consultancy-related non-audit fees to audit fees undertaken by Deloitte LLP (which are detailed on page 77 of the 2019 annual report and accounts) is in accordance with the Company's non-audit services policy, is appropriate for the advisory work required to be undertaken for the year ended 31 December 2019 and that they do not impact on the auditor's objectivity and independence.
Under the Companies Act 2006, the directors may only allot equity securities (being ordinary shares in the capital of the Company or grant rights to subscribe for or convert any security into shares), if authorised to do so by shareholders in general meeting. At last year's AGM held on 30 April 2019, shareholders granted the directors such authority to allot equity securities.
Part (a) of Resolution 13 seeks to renew that authority to allow the directors to allot equity securities up to an aggregate nominal amount of £9,675,365 representing an amount equal to one-third of the Company's issued share capital as at 19 March 2020 the latest practicable date prior to the printing of this document. The Company holds no shares in treasury ("Treasury Shares").
In addition, the Company is seeking authority in part (b) of Resolution 13 to allow the directors to allot equity securities only in connection with a rights issue up to a further nominal value of £9,675,365, representing an amount equal to one-third of the Company's issued share capital, excluding Treasury Shares, as at 19 March 2020.
The authority being sought in Resolution 13 complies with the latest guidelines issued by the Investment Association. If Resolution 13 is passed, the directors will have the authority in certain circumstances to allot equity securities up to a total nominal value of £19,350,730, representing a total amount equal to two-thirds of the Company's issued share capital, excluding Treasury Shares, as at 19 March 2020.
The directors have no present intention of exercising the authority in Resolution 13, however the directors consider it desirable to have the maximum flexibility permitted by corporate governance guidelines to manage the Company's share capital base. The authority granted in Resolution 13 will expire on the date of the Company's next AGM or 29 July 2021, whichever is the earlier.
This resolution will renew the authority granted to the Group in last year's AGM to make donations to political parties, independent election candidates and political organisations and to incur political expenditure.
The Group's policy is generally to prohibit direct or indirect political contributions and the directors have no intention of using this authority for the above purpose. What constitutes a political donation, a political party, a political organisation, or political expenditure is not easy to define, as the legislation is capable of wide interpretation. Sponsorship, subscriptions, payment of expenses, paid leave for employees fulfilling public duties, and support for bodies representing the business community in policy review or reform, may fall within this.
Accordingly, the directors have decided to seek shareholder authority for political donations and political expenditure in case any of our normal business activities are caught by the legislation. As permitted by Part 14 of the Companies Act 2006, the resolution covers any political donations made, or political expenditure incurred, by any subsidiaries of the Company. The Companies Act 2006 covers three categories: political parties and independent election candidates, political organisations and political expenditure. The directors have decided to place a cap of £50,000 per category provided that authorised political donations or political expenditure do not exceed in aggregate £50,000. The authority will expire at the conclusion of the next AGM or 29 July 2021 (whichever is earlier) and the directors expect to seek to renew this authority at each AGM.
This special resolution, if renewed, will allow the Company to call general meetings, other than the AGM, on 14 clear days' notice. The reduction in notice period to 14 days may be advantageous to the Company should it require to seek shareholder approval on any matter. However, the shorter notice period would not be routine but used only for general meetings if the Board considers that the flexibility is merited by the business of the meeting and the circumstances surrounding the business, or to keep a period of uncertainty about the future of the Company to a minimum. Examples of when the directors may consider it appropriate to call a general meeting at 14 days' notice include when significant time sensitive transactions or other price sensitive transactions are being put to shareholders for approval.
Under the Companies Act 2006, the directors may seek approval from shareholders to waive the application of statutory pre-emption rights such that the allotment of equity securities pursuant to the authority granted in Resolution 13 may be made without first having to offer it to existing shareholders in proportion to their existing holdings.
At last year's AGM shareholders passed two special resolutions in relation to the disapplication of statutory pre-emption rights.
This year, and in line with the Pre-Emption Group's Statement of Principles on the Disapplication of Pre-Emption Rights (the Preemption Group Principles) the directors have proposed again two separate resolutions to disapply pre-emption rights.
Resolution 16 will permit the directors to use the authority in Resolution 13 to allot:
a. equity securities up to a nominal amount of £19,350,730, representing two-thirds of the Company's issued share capital as at 19 March 2020 (the latest practicable date prior to publication of this document) on an offer to existing shareholders on a preemptive basis, that is including a rights issue or an open offer, with one-third being available only in connection with a rights issue as a result of the limitation on the authority in Resolution 13 (in each case subject to any adjustments, such as for fractional entitlements and overseas shareholders, as the directors see fit); and
b. equity securities up to a maximum nominal value of £1,451,305, representing approximately 5 per cent of the issued ordinary share capital of the Company as at 19 March 2020 (the latest practicable date prior to publication of this document) otherwise than in connection with a pre-emptive offer to existing shareholders.
Resolution 17 will permit the directors to allot additional equity securities up to a maximum nominal value of £1,451,305, representing approximately a further 5 per cent of the issued ordinary share capital of the Company as at 19 March 2020 (the latest practicable date prior to publication of this document), otherwise than in connection with a pre-emptive offer to existing shareholders for the purposes of financing or refinancing a transaction as contemplated by the Pre-emption Principles. The directors believe that it is appropriate to seek this additional 5 per cent authority in Resolution 17 to give the Company the flexibility that this resolution affords.
The Board confirms that, in accordance with the Pre-Emption Principles, it does not intend to issue shares for cash representing more than 7.5 per cent of the Company's issued ordinary share capital in any rolling three-year period to those who are not existing shareholders (save in accordance with Resolution 17) without prior consultation with shareholders. If passed, the authorities given in Resolution 16 and 17 will expire on the date of the Company's next AGM or 29 July 2021, whichever is the earlier.
The directors do not currently intend to allot equity securities for cash on a non pre-emptive basis pursuant to the authority in Resolution 16 and 17.
This special resolution will renew the Company's authority to make market purchases of its ordinary shares on the London Stock Exchange until the Company's next AGM or, if earlier, until 29 July 2021. The directors have no plans at present to exercise such authority and, in any event, would only do so where they believe such purchases would result in an increase in earnings per share and would be in the best interests of shareholders generally. The authority will allow the Company to purchase up to 58,052,190 ordinary shares, representing 10 per cent of the Company's issued share capital as at 19 March 2020, the latest practicable date prior to the printing of this document. The Resolution also sets out the maximum and minimum price at which any such purchase may be made.
The Company is able to hold shares purchased under this authority in treasury with a view to selling them later on, rather than cancelling them. This provides the Company with additional flexibility in the management of its capital base. For so long as any such shares are held in treasury no dividends will be paid on them and no voting rights will attach to them. If Resolution 18 is passed, it is the Company's current intention to cancel the shares it may purchase pursuant to the authority granted to it. However, in order to respond properly to the Company's capital requirements and prevailing market conditions, the directors will reassess at the time of any and each actual purchase whether to hold the shares in treasury or cancel them, provided it is permitted to do so.
The number of unissued shares that were subject to subscription options as at 19 March 2020 was approximately 6,559,000. This equals, in number, 1.13 per cent of the Company's issued shares at that date. If the proposed share purchase authority were to be exercised in full, those 6,559,000 shares would represent 1.23 per cent of the issued shares as reduced by the share purchases. As at 19 March 2020, the latest practicable date prior to the printing of this document, the Company was authorised to make market purchases of up to 58,039,485 ordinary shares pursuant to an ordinary resolution passed at the 2019 AGM on substantially the same terms as those set out in Resolution 18.
See Note 9 to the Notice of Meeting on page 8.
The corporate website which can be found at www.elementis.com. This site is frequently updated to provide shareholders with information about the Group. In particular, the Group's press releases and announcements can be found on the site together with copies of the Group's accounts.
Enquiries concerning shares or shareholdings, such as the loss of a share certificate, consolidation of share certificates, amalgamation of holdings or dividend payments, should be made to the Company's registrars:
Equiniti Group plc Aspect House Spencer Road Lancing West Sussex BN99 6DA Tel: 0371 384 2379 or +44 (0)121 415 7043 Tel: 0371 384 2255 or +44 (0)121 415 7028
For shareholders with hearing difficulties: Tel: 0371 384 2255 or +44 (0)121 415 7028
Lines are open 8.30 am to 5.30 pm, Monday to Friday (excluding public holidays in England and Wales).
In any correspondence with the registrars, please refer to Elementis plc and state clearly the registered name and address of the shareholder. Please notify the registrars promptly of any change of address.
It is in the best interests of shareholders and the Company for dividends to be paid directly into bank or building society accounts. Any shareholder who wishes to receive dividends in this way should contact the Company's registrars to obtain a dividend mandate form.
Shareholders can elect to receive shareholder documents electronically by registering with Shareview at www.shareview.co.uk. This will save on printing and distribution costs, creating environmental benefits. When you register, you will be sent an email notification to say when shareholder documents are available on our website and you will be provided with a link to that information. When registering, you will need your shareholder reference number which can be found on your share certificate or form of proxy. Please contact Equiniti if you require any assistance or further information.
Equiniti provides a share dealing service that enables shares to be bought or sold by UK shareholders by telephone or over the internet. For telephone share dealing please call 0345 603 7037 between 8.30 am and 4.30 pm (lines are open until 6.00 pm for enquiries) and for internet share dealing please visit: www.shareview.co.uk/dealing.
Share or investment scams are often run from 'boiler rooms' where fraudsters cold call investors offering them worthless, overpriced or even non-existent shares, or offer to buy their shares in a company at a higher price than the market value. Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount, or offers of free reports about the company. Even seasoned investors have been caught out by such fraudsters. The FCA have some helpful information.
If you are contacted by a cold caller, you should inform the Company Secretary by email and also the FCA by using their share fraud reporting form at www.fca.org.uk/scams or calling their Consumer Helpline on 0800 111 6768.
If you have already paid money to a share fraudster, please contact Action Fraud on 0300 123 2040 or www.actionfraud.police.uk.
Laura Higgins
Caroline House 55-57 High Holborn London WC1V 6DX UK
3299608
Deloitte LLP
J.P. Morgan Cazenove Numis
Tulchan Communications
| 4 March 2020 | Preliminary announcement of final results for the year ended 31 December 2019 |
|---|---|
| 29 April 2020 | Annual General Meeting |
| 29 April 2020 | Trading update |
| 28 July 2020* | Interim results announcement for the half year ending 30 June 2020 |
| 3 September 2020* | Ex-dividend date for interim dividend for 2020 payable on ordinary shares |
| 4 September 2020* | Record date for interim dividend for 2020 payable on ordinary shares |
| 25 September 2020* | Payment of interim dividend for 2020 on ordinary shares |
* Provisional date
ELEMENTIS PLC
Caroline House 55-57 High Holborn London WC1V 6DX UK
Tel: +44 (0) 20 7067 2999 Email: [email protected] Website: www.elementis.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.